nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER2—Ovarian Infertility Genes—VDR—psoriasis	0.000831	0.0802	CbGpPWpGaD
Misoprostol—Arrhythmia—Betamethasone—psoriasis	0.000751	0.000759	CcSEcCtD
Misoprostol—Alopecia—Dexamethasone—psoriasis	0.000743	0.000751	CcSEcCtD
Misoprostol—Alopecia—Betamethasone—psoriasis	0.000743	0.000751	CcSEcCtD
Misoprostol—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000742	0.00075	CcSEcCtD
Misoprostol—Hypertension—Hydrocortisone—psoriasis	0.00074	0.000747	CcSEcCtD
Misoprostol—Vomiting—Hydroxyurea—psoriasis	0.000738	0.000746	CcSEcCtD
Misoprostol—Rash—Hydroxyurea—psoriasis	0.000732	0.00074	CcSEcCtD
Misoprostol—Dermatitis—Hydroxyurea—psoriasis	0.000732	0.000739	CcSEcCtD
Misoprostol—Myalgia—Hydrocortisone—psoriasis	0.000729	0.000737	CcSEcCtD
Misoprostol—Headache—Hydroxyurea—psoriasis	0.000727	0.000735	CcSEcCtD
Misoprostol—Anxiety—Hydrocortisone—psoriasis	0.000727	0.000735	CcSEcCtD
Misoprostol—Syncope—Triamcinolone—psoriasis	0.000723	0.000731	CcSEcCtD
Misoprostol—Hypotension—Mycophenolate mofetil—psoriasis	0.000717	0.000725	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000717	0.000724	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisolone—psoriasis	0.000716	0.000723	CcSEcCtD
Misoprostol—Oedema—Prednisolone—psoriasis	0.000716	0.000723	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—psoriasis	0.000715	0.000722	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Methotrexate—psoriasis	0.000711	0.000718	CcSEcCtD
Misoprostol—Loss of consciousness—Triamcinolone—psoriasis	0.000709	0.000717	CcSEcCtD
Misoprostol—Shock—Prednisolone—psoriasis	0.000704	0.000712	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—psoriasis	0.000704	0.000712	CcSEcCtD
Misoprostol—Dyspnoea—Cyclosporine—psoriasis	0.000701	0.000709	CcSEcCtD
Misoprostol—Somnolence—Cyclosporine—psoriasis	0.000699	0.000707	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000699	0.000707	CcSEcCtD
Misoprostol—Anaphylactic shock—Hydrocortisone—psoriasis	0.000699	0.000707	CcSEcCtD
Misoprostol—Oedema—Hydrocortisone—psoriasis	0.000699	0.000707	CcSEcCtD
Misoprostol—Asthenia—Mycophenolic acid—psoriasis	0.000698	0.000705	CcSEcCtD
Misoprostol—Hypertension—Triamcinolone—psoriasis	0.000697	0.000704	CcSEcCtD
Misoprostol—Infection—Hydrocortisone—psoriasis	0.000695	0.000702	CcSEcCtD
Misoprostol—Dyspepsia—Cyclosporine—psoriasis	0.000693	0.0007	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisolone—psoriasis	0.000692	0.000699	CcSEcCtD
Misoprostol—Nausea—Hydroxyurea—psoriasis	0.00069	0.000697	CcSEcCtD
Misoprostol—Shock—Hydrocortisone—psoriasis	0.000688	0.000695	CcSEcCtD
Misoprostol—Myalgia—Triamcinolone—psoriasis	0.000687	0.000694	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—psoriasis	0.000686	0.000693	CcSEcCtD
Misoprostol—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000684	0.000691	CcSEcCtD
Misoprostol—Somnolence—Mycophenolate mofetil—psoriasis	0.000682	0.000689	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—psoriasis	0.000682	0.000689	CcSEcCtD
Misoprostol—Fatigue—Cyclosporine—psoriasis	0.000678	0.000685	CcSEcCtD
Misoprostol—Hyperhidrosis—Hydrocortisone—psoriasis	0.000676	0.000683	CcSEcCtD
Misoprostol—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000676	0.000683	CcSEcCtD
Misoprostol—Constipation—Cyclosporine—psoriasis	0.000673	0.00068	CcSEcCtD
Misoprostol—Pain—Cyclosporine—psoriasis	0.000673	0.00068	CcSEcCtD
Misoprostol—Diarrhoea—Mycophenolic acid—psoriasis	0.000665	0.000672	CcSEcCtD
Misoprostol—Conjunctivitis—Methotrexate—psoriasis	0.000663	0.00067	CcSEcCtD
Misoprostol—Immune system disorder—Prednisone—psoriasis	0.000661	0.000668	CcSEcCtD
Misoprostol—Anaphylactic shock—Triamcinolone—psoriasis	0.000658	0.000665	CcSEcCtD
Misoprostol—Oedema—Triamcinolone—psoriasis	0.000658	0.000665	CcSEcCtD
Misoprostol—Syncope—Betamethasone—psoriasis	0.000656	0.000663	CcSEcCtD
Misoprostol—Syncope—Dexamethasone—psoriasis	0.000656	0.000663	CcSEcCtD
Misoprostol—Pain—Mycophenolate mofetil—psoriasis	0.000656	0.000663	CcSEcCtD
Misoprostol—Constipation—Mycophenolate mofetil—psoriasis	0.000656	0.000663	CcSEcCtD
Misoprostol—Arrhythmia—Prednisone—psoriasis	0.000654	0.000661	CcSEcCtD
Misoprostol—Infection—Triamcinolone—psoriasis	0.000654	0.000661	CcSEcCtD
Misoprostol—Hypotension—Hydrocortisone—psoriasis	0.000653	0.00066	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—psoriasis	0.00065	0.000657	CcSEcCtD
Misoprostol—Feeling abnormal—Cyclosporine—psoriasis	0.000648	0.000655	CcSEcCtD
Misoprostol—Shock—Triamcinolone—psoriasis	0.000648	0.000655	CcSEcCtD
Misoprostol—Alopecia—Prednisone—psoriasis	0.000647	0.000654	CcSEcCtD
Misoprostol—Gastrointestinal pain—Cyclosporine—psoriasis	0.000643	0.00065	CcSEcCtD
Misoprostol—Loss of consciousness—Dexamethasone—psoriasis	0.000643	0.00065	CcSEcCtD
Misoprostol—Loss of consciousness—Betamethasone—psoriasis	0.000643	0.00065	CcSEcCtD
Misoprostol—Dizziness—Mycophenolic acid—psoriasis	0.000643	0.00065	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—psoriasis	0.000643	0.00065	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000637	0.000644	CcSEcCtD
Misoprostol—Hyperhidrosis—Triamcinolone—psoriasis	0.000637	0.000643	CcSEcCtD
Misoprostol—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000633	0.000639	CcSEcCtD
Misoprostol—Hypertension—Dexamethasone—psoriasis	0.000632	0.000639	CcSEcCtD
Misoprostol—Hypertension—Betamethasone—psoriasis	0.000632	0.000639	CcSEcCtD
Misoprostol—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000628	0.000634	CcSEcCtD
Misoprostol—Myalgia—Dexamethasone—psoriasis	0.000623	0.00063	CcSEcCtD
Misoprostol—Myalgia—Betamethasone—psoriasis	0.000623	0.00063	CcSEcCtD
Misoprostol—Body temperature increased—Cyclosporine—psoriasis	0.000622	0.000629	CcSEcCtD
Misoprostol—Abdominal pain—Cyclosporine—psoriasis	0.000622	0.000629	CcSEcCtD
Misoprostol—Anxiety—Betamethasone—psoriasis	0.000621	0.000628	CcSEcCtD
Misoprostol—Anxiety—Dexamethasone—psoriasis	0.000621	0.000628	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000619	0.0597	CbGpPWpGaD
Misoprostol—Vomiting—Mycophenolic acid—psoriasis	0.000618	0.000625	CcSEcCtD
Misoprostol—Dyspepsia—Hydrocortisone—psoriasis	0.000616	0.000622	CcSEcCtD
Misoprostol—Rash—Mycophenolic acid—psoriasis	0.000613	0.00062	CcSEcCtD
Misoprostol—Dermatitis—Mycophenolic acid—psoriasis	0.000613	0.000619	CcSEcCtD
Misoprostol—Pain—Prednisolone—psoriasis	0.000612	0.000619	CcSEcCtD
Misoprostol—Headache—Mycophenolic acid—psoriasis	0.000609	0.000616	CcSEcCtD
Misoprostol—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000607	0.000613	CcSEcCtD
Misoprostol—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000607	0.000613	CcSEcCtD
Misoprostol—Fatigue—Hydrocortisone—psoriasis	0.000603	0.000609	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.0006	0.000606	CcSEcCtD
Misoprostol—Pain—Hydrocortisone—psoriasis	0.000598	0.000604	CcSEcCtD
Misoprostol—Oedema—Betamethasone—psoriasis	0.000597	0.000604	CcSEcCtD
Misoprostol—Anaphylactic shock—Dexamethasone—psoriasis	0.000597	0.000604	CcSEcCtD
Misoprostol—Anaphylactic shock—Betamethasone—psoriasis	0.000597	0.000604	CcSEcCtD
Misoprostol—Oedema—Dexamethasone—psoriasis	0.000597	0.000604	CcSEcCtD
Misoprostol—Infection—Dexamethasone—psoriasis	0.000594	0.0006	CcSEcCtD
Misoprostol—Infection—Betamethasone—psoriasis	0.000594	0.0006	CcSEcCtD
Misoprostol—Feeling abnormal—Prednisolone—psoriasis	0.00059	0.000596	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—HCAR2—psoriasis	0.00059	0.0569	CbGpPWpGaD
Misoprostol—Visual impairment—Methotrexate—psoriasis	0.00059	0.000596	CcSEcCtD
Misoprostol—Anaemia—Prednisone—psoriasis	0.000589	0.000595	CcSEcCtD
Misoprostol—Shock—Dexamethasone—psoriasis	0.000588	0.000594	CcSEcCtD
Misoprostol—Shock—Betamethasone—psoriasis	0.000588	0.000594	CcSEcCtD
Misoprostol—Dyspnoea—Triamcinolone—psoriasis	0.000587	0.000593	CcSEcCtD
Misoprostol—Thrombocytopenia—Dexamethasone—psoriasis	0.000585	0.000591	CcSEcCtD
Misoprostol—Thrombocytopenia—Betamethasone—psoriasis	0.000585	0.000591	CcSEcCtD
Misoprostol—Hypersensitivity—Cyclosporine—psoriasis	0.00058	0.000586	CcSEcCtD
Misoprostol—Dyspepsia—Triamcinolone—psoriasis	0.00058	0.000586	CcSEcCtD
Misoprostol—Nausea—Mycophenolic acid—psoriasis	0.000578	0.000584	CcSEcCtD
Misoprostol—Hyperhidrosis—Dexamethasone—psoriasis	0.000578	0.000584	CcSEcCtD
Misoprostol—Hyperhidrosis—Betamethasone—psoriasis	0.000578	0.000584	CcSEcCtD
Misoprostol—Feeling abnormal—Hydrocortisone—psoriasis	0.000576	0.000582	CcSEcCtD
Misoprostol—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000572	0.000578	CcSEcCtD
Misoprostol—Syncope—Prednisone—psoriasis	0.000572	0.000578	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—psoriasis	0.000571	0.000577	CcSEcCtD
Misoprostol—Fatigue—Triamcinolone—psoriasis	0.000568	0.000574	CcSEcCtD
Misoprostol—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000565	0.000571	CcSEcCtD
Misoprostol—Asthenia—Cyclosporine—psoriasis	0.000565	0.00057	CcSEcCtD
Misoprostol—Pain—Triamcinolone—psoriasis	0.000563	0.000569	CcSEcCtD
Misoprostol—Loss of consciousness—Prednisone—psoriasis	0.00056	0.000566	CcSEcCtD
Misoprostol—Hypotension—Dexamethasone—psoriasis	0.000558	0.000564	CcSEcCtD
Misoprostol—Hypotension—Betamethasone—psoriasis	0.000558	0.000564	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—psoriasis	0.000553	0.000559	CcSEcCtD
Misoprostol—Abdominal pain—Hydrocortisone—psoriasis	0.000553	0.000559	CcSEcCtD
Misoprostol—Body temperature increased—Hydrocortisone—psoriasis	0.000553	0.000559	CcSEcCtD
Misoprostol—Asthenia—Mycophenolate mofetil—psoriasis	0.000551	0.000556	CcSEcCtD
Misoprostol—Hypertension—Prednisone—psoriasis	0.00055	0.000556	CcSEcCtD
Misoprostol—Chills—Methotrexate—psoriasis	0.000549	0.000555	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000544	0.00055	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000544	0.00055	CcSEcCtD
Misoprostol—Myalgia—Prednisone—psoriasis	0.000543	0.000548	CcSEcCtD
Misoprostol—Arthralgia—Prednisone—psoriasis	0.000543	0.000548	CcSEcCtD
Misoprostol—Feeling abnormal—Triamcinolone—psoriasis	0.000543	0.000548	CcSEcCtD
Misoprostol—Anxiety—Prednisone—psoriasis	0.000541	0.000547	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—psoriasis	0.000541	0.000546	CcSEcCtD
Misoprostol—Diarrhoea—Cyclosporine—psoriasis	0.000538	0.000544	CcSEcCtD
Misoprostol—Hypersensitivity—Prednisolone—psoriasis	0.000528	0.000533	CcSEcCtD
Misoprostol—Dyspepsia—Dexamethasone—psoriasis	0.000526	0.000531	CcSEcCtD
Misoprostol—Dyspepsia—Betamethasone—psoriasis	0.000526	0.000531	CcSEcCtD
Misoprostol—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000525	0.000531	CcSEcCtD
Misoprostol—Body temperature increased—Triamcinolone—psoriasis	0.000521	0.000526	CcSEcCtD
Misoprostol—Dizziness—Cyclosporine—psoriasis	0.00052	0.000526	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisone—psoriasis	0.00052	0.000526	CcSEcCtD
Misoprostol—Oedema—Prednisone—psoriasis	0.00052	0.000526	CcSEcCtD
Misoprostol—Infection—Prednisone—psoriasis	0.000517	0.000522	CcSEcCtD
Misoprostol—Back pain—Methotrexate—psoriasis	0.000515	0.000521	CcSEcCtD
Misoprostol—Hypersensitivity—Hydrocortisone—psoriasis	0.000515	0.000521	CcSEcCtD
Misoprostol—Fatigue—Dexamethasone—psoriasis	0.000515	0.00052	CcSEcCtD
Misoprostol—Fatigue—Betamethasone—psoriasis	0.000515	0.00052	CcSEcCtD
Misoprostol—Shock—Prednisone—psoriasis	0.000512	0.000517	CcSEcCtD
Misoprostol—Pain—Dexamethasone—psoriasis	0.000511	0.000516	CcSEcCtD
Misoprostol—Pain—Betamethasone—psoriasis	0.000511	0.000516	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000508	0.049	CbGpPWpGaD
Misoprostol—Dizziness—Mycophenolate mofetil—psoriasis	0.000508	0.000513	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisone—psoriasis	0.000503	0.000508	CcSEcCtD
Misoprostol—Asthenia—Hydrocortisone—psoriasis	0.000502	0.000507	CcSEcCtD
Misoprostol—Vomiting—Cyclosporine—psoriasis	0.0005	0.000506	CcSEcCtD
Misoprostol—Rash—Cyclosporine—psoriasis	0.000496	0.000501	CcSEcCtD
Misoprostol—Dermatitis—Cyclosporine—psoriasis	0.000496	0.000501	CcSEcCtD
Misoprostol—Headache—Cyclosporine—psoriasis	0.000493	0.000498	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—psoriasis	0.000492	0.000498	CcSEcCtD
Misoprostol—Feeling abnormal—Dexamethasone—psoriasis	0.000492	0.000497	CcSEcCtD
Misoprostol—Feeling abnormal—Betamethasone—psoriasis	0.000492	0.000497	CcSEcCtD
Misoprostol—Gastrointestinal pain—Betamethasone—psoriasis	0.000489	0.000494	CcSEcCtD
Misoprostol—Gastrointestinal pain—Dexamethasone—psoriasis	0.000489	0.000494	CcSEcCtD
Misoprostol—Vomiting—Mycophenolate mofetil—psoriasis	0.000488	0.000493	CcSEcCtD
Misoprostol—Hypersensitivity—Triamcinolone—psoriasis	0.000485	0.00049	CcSEcCtD
Misoprostol—Rash—Mycophenolate mofetil—psoriasis	0.000484	0.000489	CcSEcCtD
Misoprostol—Dermatitis—Mycophenolate mofetil—psoriasis	0.000484	0.000489	CcSEcCtD
Misoprostol—Headache—Mycophenolate mofetil—psoriasis	0.000481	0.000486	CcSEcCtD
Misoprostol—Diarrhoea—Hydrocortisone—psoriasis	0.000478	0.000483	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Prednisone—psoriasis	0.000474	0.000479	CcSEcCtD
Misoprostol—Dizziness—Prednisolone—psoriasis	0.000473	0.000478	CcSEcCtD
Misoprostol—Asthenia—Triamcinolone—psoriasis	0.000472	0.000477	CcSEcCtD
Misoprostol—Abdominal pain—Betamethasone—psoriasis	0.000472	0.000477	CcSEcCtD
Misoprostol—Body temperature increased—Dexamethasone—psoriasis	0.000472	0.000477	CcSEcCtD
Misoprostol—Abdominal pain—Dexamethasone—psoriasis	0.000472	0.000477	CcSEcCtD
Misoprostol—Body temperature increased—Betamethasone—psoriasis	0.000472	0.000477	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—HCAR2—psoriasis	0.000471	0.0455	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000469	0.0453	CbGpPWpGaD
Misoprostol—Nausea—Cyclosporine—psoriasis	0.000467	0.000472	CcSEcCtD
Misoprostol—Dizziness—Hydrocortisone—psoriasis	0.000462	0.000467	CcSEcCtD
Misoprostol—Dyspepsia—Prednisone—psoriasis	0.000458	0.000463	CcSEcCtD
Misoprostol—Nausea—Mycophenolate mofetil—psoriasis	0.000456	0.000461	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—psoriasis	0.000454	0.000458	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—psoriasis	0.000454	0.000458	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—psoriasis	0.000454	0.000458	CcSEcCtD
Misoprostol—Rash—Prednisolone—psoriasis	0.000451	0.000456	CcSEcCtD
Misoprostol—Dermatitis—Prednisolone—psoriasis	0.000451	0.000456	CcSEcCtD
Misoprostol—Fatigue—Prednisone—psoriasis	0.000449	0.000453	CcSEcCtD
Misoprostol—Headache—Prednisolone—psoriasis	0.000449	0.000453	CcSEcCtD
Misoprostol—Constipation—Prednisone—psoriasis	0.000445	0.00045	CcSEcCtD
Misoprostol—Vomiting—Hydrocortisone—psoriasis	0.000445	0.000449	CcSEcCtD
Misoprostol—Rash—Hydrocortisone—psoriasis	0.000441	0.000446	CcSEcCtD
Misoprostol—Dermatitis—Hydrocortisone—psoriasis	0.00044	0.000445	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—psoriasis	0.000438	0.000443	CcSEcCtD
Misoprostol—Headache—Hydrocortisone—psoriasis	0.000438	0.000443	CcSEcCtD
Misoprostol—Dizziness—Triamcinolone—psoriasis	0.000435	0.00044	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—psoriasis	0.000435	0.000439	CcSEcCtD
Misoprostol—Infection—Methotrexate—psoriasis	0.000432	0.000436	CcSEcCtD
Misoprostol—Feeling abnormal—Prednisone—psoriasis	0.000429	0.000433	CcSEcCtD
Misoprostol—Asthenia—Betamethasone—psoriasis	0.000429	0.000433	CcSEcCtD
Misoprostol—Asthenia—Dexamethasone—psoriasis	0.000429	0.000433	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—psoriasis	0.000426	0.00043	CcSEcCtD
Misoprostol—Gastrointestinal pain—Prednisone—psoriasis	0.000425	0.00043	CcSEcCtD
Misoprostol—Nausea—Prednisolone—psoriasis	0.000425	0.00043	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—psoriasis	0.00042	0.000425	CcSEcCtD
Misoprostol—Vomiting—Triamcinolone—psoriasis	0.000419	0.000423	CcSEcCtD
Misoprostol—Nausea—Hydrocortisone—psoriasis	0.000415	0.00042	CcSEcCtD
Misoprostol—Rash—Triamcinolone—psoriasis	0.000415	0.000419	CcSEcCtD
Misoprostol—Dermatitis—Triamcinolone—psoriasis	0.000415	0.000419	CcSEcCtD
Misoprostol—Headache—Triamcinolone—psoriasis	0.000412	0.000417	CcSEcCtD
Misoprostol—Body temperature increased—Prednisone—psoriasis	0.000411	0.000416	CcSEcCtD
Misoprostol—Abdominal pain—Prednisone—psoriasis	0.000411	0.000416	CcSEcCtD
Misoprostol—Diarrhoea—Dexamethasone—psoriasis	0.000409	0.000413	CcSEcCtD
Misoprostol—Diarrhoea—Betamethasone—psoriasis	0.000409	0.000413	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—psoriasis	0.000406	0.000411	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000396	0.0004	CcSEcCtD
Misoprostol—Dizziness—Betamethasone—psoriasis	0.000395	0.000399	CcSEcCtD
Misoprostol—Dizziness—Dexamethasone—psoriasis	0.000395	0.000399	CcSEcCtD
Misoprostol—Nausea—Triamcinolone—psoriasis	0.000391	0.000395	CcSEcCtD
Misoprostol—Dyspnoea—Methotrexate—psoriasis	0.000388	0.000392	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—HCAR2—psoriasis	0.000387	0.0373	CbGpPWpGaD
Misoprostol—Somnolence—Methotrexate—psoriasis	0.000387	0.000391	CcSEcCtD
Misoprostol—Hypersensitivity—Prednisone—psoriasis	0.000383	0.000387	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—psoriasis	0.000383	0.000387	CcSEcCtD
Misoprostol—Vomiting—Betamethasone—psoriasis	0.00038	0.000384	CcSEcCtD
Misoprostol—Vomiting—Dexamethasone—psoriasis	0.00038	0.000384	CcSEcCtD
Misoprostol—Rash—Dexamethasone—psoriasis	0.000377	0.000381	CcSEcCtD
Misoprostol—Rash—Betamethasone—psoriasis	0.000377	0.000381	CcSEcCtD
Misoprostol—Dermatitis—Betamethasone—psoriasis	0.000376	0.00038	CcSEcCtD
Misoprostol—Dermatitis—Dexamethasone—psoriasis	0.000376	0.00038	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—psoriasis	0.000375	0.000379	CcSEcCtD
Misoprostol—Headache—Dexamethasone—psoriasis	0.000374	0.000378	CcSEcCtD
Misoprostol—Headache—Betamethasone—psoriasis	0.000374	0.000378	CcSEcCtD
Misoprostol—Asthenia—Prednisone—psoriasis	0.000373	0.000377	CcSEcCtD
Misoprostol—Pain—Methotrexate—psoriasis	0.000372	0.000376	CcSEcCtD
Misoprostol—Feeling abnormal—Methotrexate—psoriasis	0.000358	0.000362	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—HCAR2—psoriasis	0.000357	0.0345	CbGpPWpGaD
Misoprostol—Diarrhoea—Prednisone—psoriasis	0.000356	0.00036	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—psoriasis	0.000356	0.000359	CcSEcCtD
Misoprostol—Nausea—Betamethasone—psoriasis	0.000355	0.000359	CcSEcCtD
Misoprostol—Nausea—Dexamethasone—psoriasis	0.000355	0.000359	CcSEcCtD
Misoprostol—Dizziness—Prednisone—psoriasis	0.000344	0.000348	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—psoriasis	0.000344	0.000347	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—psoriasis	0.000344	0.000347	CcSEcCtD
Misoprostol—Vomiting—Prednisone—psoriasis	0.000331	0.000334	CcSEcCtD
Misoprostol—Rash—Prednisone—psoriasis	0.000328	0.000331	CcSEcCtD
Misoprostol—Dermatitis—Prednisone—psoriasis	0.000328	0.000331	CcSEcCtD
Misoprostol—Headache—Prednisone—psoriasis	0.000326	0.000329	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000321	0.031	CbGpPWpGaD
Misoprostol—Hypersensitivity—Methotrexate—psoriasis	0.00032	0.000324	CcSEcCtD
Misoprostol—Asthenia—Methotrexate—psoriasis	0.000312	0.000315	CcSEcCtD
Misoprostol—Nausea—Prednisone—psoriasis	0.000309	0.000312	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—CCL20—psoriasis	0.000306	0.0296	CbGpPWpGaD
Misoprostol—Diarrhoea—Methotrexate—psoriasis	0.000298	0.000301	CcSEcCtD
Misoprostol—Dizziness—Methotrexate—psoriasis	0.000288	0.000291	CcSEcCtD
Misoprostol—Vomiting—Methotrexate—psoriasis	0.000276	0.000279	CcSEcCtD
Misoprostol—Rash—Methotrexate—psoriasis	0.000274	0.000277	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—psoriasis	0.000274	0.000277	CcSEcCtD
Misoprostol—Headache—Methotrexate—psoriasis	0.000272	0.000275	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—HCAR2—psoriasis	0.000266	0.0257	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000264	0.0255	CbGpPWpGaD
Misoprostol—Nausea—Methotrexate—psoriasis	0.000258	0.000261	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCL20—psoriasis	0.000245	0.0236	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000244	0.0235	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HCAR2—psoriasis	0.000242	0.0233	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—HCAR2—psoriasis	0.000219	0.0211	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HCAR2—psoriasis	0.000202	0.0195	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL20—psoriasis	0.000201	0.0194	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HCAR2—psoriasis	0.000199	0.0192	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL20—psoriasis	0.000185	0.0179	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HCAR2—psoriasis	0.000183	0.0177	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HCAR2—psoriasis	0.000143	0.0138	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CCL20—psoriasis	0.000138	0.0134	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL20—psoriasis	0.000126	0.0121	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TAGAP—psoriasis	0.000124	0.012	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HCAR2—psoriasis	0.000117	0.0113	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CCL20—psoriasis	0.000114	0.011	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HCAR2—psoriasis	0.000108	0.0104	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CCL20—psoriasis	0.000105	0.0101	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL20—psoriasis	0.000103	0.00996	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TAGAP—psoriasis	0.000102	0.00982	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL20—psoriasis	9.52e-05	0.00919	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TAGAP—psoriasis	9.39e-05	0.00906	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	8.68e-05	0.00838	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL8—psoriasis	8.27e-05	0.00799	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL20—psoriasis	7.42e-05	0.00716	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	7.13e-05	0.00688	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL8—psoriasis	6.61e-05	0.00638	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.58e-05	0.00635	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL20—psoriasis	6.09e-05	0.00588	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL20—psoriasis	5.62e-05	0.00543	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCL8—psoriasis	5.43e-05	0.00524	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCL8—psoriasis	5.01e-05	0.00483	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SOCS1—psoriasis	4.09e-05	0.00394	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—TYK2—psoriasis	3.9e-05	0.00376	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL8—psoriasis	3.74e-05	0.00361	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—psoriasis	3.39e-05	0.00327	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SOCS1—psoriasis	3.36e-05	0.00324	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—TYK2—psoriasis	3.2e-05	0.00309	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SOCS1—psoriasis	3.1e-05	0.00299	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—psoriasis	3.07e-05	0.00296	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LEP—psoriasis	3.02e-05	0.00291	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOE—psoriasis	3.02e-05	0.00291	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—TYK2—psoriasis	2.95e-05	0.00285	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—psoriasis	2.83e-05	0.00273	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NFKBIA—psoriasis	2.81e-05	0.00271	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—psoriasis	2.79e-05	0.00269	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—psoriasis	2.57e-05	0.00248	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOE—psoriasis	2.48e-05	0.00239	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—psoriasis	2.48e-05	0.00239	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NFKBIA—psoriasis	2.31e-05	0.00223	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TYK2—psoriasis	2.3e-05	0.00222	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOE—psoriasis	2.29e-05	0.00221	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—psoriasis	2.29e-05	0.00221	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NFKBIA—psoriasis	2.13e-05	0.00206	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—psoriasis	2e-05	0.00193	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—psoriasis	1.91e-05	0.00184	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TYK2—psoriasis	1.89e-05	0.00182	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JUN—psoriasis	1.86e-05	0.0018	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NFKB1—psoriasis	1.79e-05	0.00173	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TYK2—psoriasis	1.74e-05	0.00168	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—psoriasis	1.65e-05	0.00159	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—psoriasis	1.63e-05	0.00157	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—psoriasis	1.61e-05	0.00156	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—psoriasis	1.56e-05	0.00151	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JUN—psoriasis	1.53e-05	0.00148	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—psoriasis	1.52e-05	0.00147	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NFKB1—psoriasis	1.47e-05	0.00142	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—psoriasis	1.44e-05	0.00139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JUN—psoriasis	1.41e-05	0.00136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NFKB1—psoriasis	1.36e-05	0.00131	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—psoriasis	1.34e-05	0.00129	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—psoriasis	1.32e-05	0.00128	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—psoriasis	1.23e-05	0.00119	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—psoriasis	1.23e-05	0.00119	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—psoriasis	1.22e-05	0.00118	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—psoriasis	1.13e-05	0.00109	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—psoriasis	1.01e-05	0.000975	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—psoriasis	9.32e-06	0.000899	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—psoriasis	9.24e-06	0.000892	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—psoriasis	8.53e-06	0.000823	CbGpPWpGaD
